35 related articles for article (PubMed ID: 27127158)
21. Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib.
Fiala O; Pesek M; Finek J; Racek J; Minarik M; Benesova L; Bortlicek Z; Sorejs O; Kucera R; Topolcan O
Neoplasma; 2016; 63(3):471-6. PubMed ID: 26952513
[TBL] [Abstract][Full Text] [Related]
22. Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC.
Fiala O; Hosek P; Pesek M; Finek J; Racek J; Stehlik P; Sorejs O; Minarik M; Benesova L; Celer A; Nemcova I; Kucera R; Topolcan O
Anticancer Res; 2017 Nov; 37(11):6469-6476. PubMed ID: 29061834
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer.
Zhou S; Ren S; Yan L; Zhang L; Tang L; Zhang J; Zhou C
Respirology; 2009 Jul; 14(5):709-15. PubMed ID: 19659649
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphism in the epidermal growth factor receptor gene predicts outcome in advanced non-small cell lung cancer patients treated with erlotinib.
Winther-Larsen A; Nissen PH; Jakobsen KR; Demuth C; Sorensen BS; Meldgaard P
Lung Cancer; 2015 Nov; 90(2):314-20. PubMed ID: 26386832
[TBL] [Abstract][Full Text] [Related]
25. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
26. Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib.
Fiala O; Pesek M; Finek J; Topolcan O; Racek J; Svaton M; Kucera R; Minarik M; Benesova L; Bortlicek Z; Chloupkova R; Poprach A; Buchler T
Anticancer Res; 2016 May; 36(5):2459-65. PubMed ID: 27127158
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis.
Zhang X; Guo M; Fan J; Lv Z; Huang Q; Han J; Wu F; Hu G; Xu J; Jin Y
Cancer Biomark; 2016; 16(3):415-23. PubMed ID: 27062698
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis.
Zhang J; Yao YH; Li BG; Yang Q; Zhang PY; Wang HT
Sci Rep; 2015 Apr; 5():9800. PubMed ID: 25902419
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies.
Petrelli F; Cabiddu M; Coinu A; Borgonovo K; Ghilardi M; Lonati V; Barni S
Acta Oncol; 2015 Jul; 54(7):961-70. PubMed ID: 25984930
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]